|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 February 2001, Vol. 97, No. 4, pp. 895-900
HEMATOPOIESIS
Telomere length in leukocyte subpopulations of patients with
aplastic anemia
Tim H. Brümmendorf,
Jaroslaw P. Maciejewski,
Jennifer Mak,
Neal S. Young, and
Peter M. Lansdorp
From the Terry Fox Laboratory, British Columbia Cancer
Agency, and the Department of Medicine, University of British Columbia,
Vancouver, BC, Canada; the Abteilung Hämatologie, Onkologie und
Immunologie, Medizinische Universitätsklinik,
Tübingen, Germany; and the Hematology Branch, National Heart,
Lung and Blood Institute, National Institutes of Health, Bethesda, MD.
In most human cells, the average length of telomere repeats
at the ends of chromosomes provides indirect information about their
mitotic history. To study the turnover of stem cells in patients with
bone marrow failure syndromes, the telomere length in peripheral blood
granulocytes and lymphocytes from patients with aplastic anemia (AA,
n = 56) and hemolytic paroxysmal nocturnal hemoglobinuria (n = 6)
was analyzed relative to age-matched controls by means of fluorescence
in situ hybridization and flow cytometry. The telomere lengths
in granulocytes from patients with AA were found to be significantly
shorter than those in age-adjusted controls (P = .001).
However, surprisingly, telomere length in granulocytes from AA patients
who had recovered after immunosuppressive therapy did not differ
significantly from controls, whereas untreated patients and
nonresponders with persistent severe pancytopenia showed marked and
significant telomere shortening. These results support extensive
proliferation of hematopoietic stem cells in subgroups of AA patients.
Because normal individuals show significant variation in telomere
length, individual measurements in blood cells from AA patients may be
of limited value. Whether sequential telomere length measurements can
be used as a prognostic tool in this group of disorders remains to be clarified.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. T. Cronkhite, C. Xing, G. Raghu, K. M. Chin, F. Torres, R. L. Rosenblatt, and C. K. Garcia
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Spyridopoulos, Y. Erben, T. H. Brummendorf, J. Haendeler, K. Dietz, F. Seeger, C. K. Kissel, H. Martin, J. Hoffmann, B. Assmus, et al.
Telomere Gap Between Granulocytes and Lymphocytes Is a Determinant for Hematopoetic Progenitor Cell Impairment in Patients With Previous Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2008;
28(5):
968 - 974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Calado and N. S. Young
Telomere maintenance and human bone marrow failure
Blood,
May 1, 2008;
111(9):
4446 - 4455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Goldman, G. Aubert, A. J. Klingelhutz, M. Hills, S. R. Cooper, W. S. Hamilton, A. J. Schlueter, K. Lambie, C. J. Eaves, and P. M. Lansdorp
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Blood,
May 1, 2008;
111(9):
4523 - 4531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, A. Walne, H. Tamary, Y. Masunari, M. Kirwan, R. Beswick, T. Vulliamy, and I. Dokal
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome
Blood,
December 15, 2007;
110(13):
4198 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Garcia, W. E. Wright, and J. W. Shay
Human diseases of telomerase dysfunction: insights into tissue aging
Nucleic Acids Res.,
December 3, 2007;
35(22):
7406 - 7416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, H. Yagasaki, A. Hama, N. Nishio, Y. Takahashi, and S. Kojima
Mutation of SBDS and SH2D1A is not associated with aplastic anemia in Japanese children
Haematologica,
November 1, 2007;
92(11):
1573 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Alter, G. M. Baerlocher, S. A. Savage, S. J. Chanock, B. B. Weksler, J. P. Willner, J. A. Peters, N. Giri, and P. M. Lansdorp
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita
Blood,
September 1, 2007;
110(5):
1439 - 1447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Calado, S. A. Graf, K. L. Wilkerson, S. Kajigaya, P. J. Ancliff, Y. Dror, S. J. Chanock, P. M. Lansdorp, and N. S. Young
Mutations in the SBDS gene in acquired aplastic anemia
Blood,
August 15, 2007;
110(4):
1141 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, P. Sokhal, A. Walne, R. Beswick, M. Kirwan, S. Killick, M. Williams, J. Marsh, T. Vulliamy, and I. Dokal
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations
Haematologica,
August 1, 2007;
92(8):
1013 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Drummond, S. Balabanov, T. L. Holyoake, and T. H. Brummendorf
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells
Stem Cells,
August 1, 2007;
25(8):
1853 - 1861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Alter
Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Hematology,
January 1, 2007;
2007(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Young, R. T. Calado, and P. Scheinberg
Current concepts in the pathophysiology and treatment of aplastic anemia
Blood,
October 15, 2006;
108(8):
2509 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Vulliamy, A. Marrone, S. W. Knight, A. Walne, P. J. Mason, and I. Dokal
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation
Blood,
April 1, 2006;
107(7):
2680 - 2685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Austin, R. J. Leary, and A. Shimamura
The Shwachman-Diamond SBDS protein localizes to the nucleolus
Blood,
August 15, 2005;
106(4):
1253 - 1258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Beier, S. Balabanov, T. Buckley, K. Dietz, U. Hartmann, M. Rojewski, L. Kanz, H. Schrezenmeier, and T. H. Brummendorf
Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH
Blood,
July 15, 2005;
106(2):
531 - 533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yamaguchi, R. T. Calado, H. Ly, S. Kajigaya, G. M. Baerlocher, S. J. Chanock, P. M. Lansdorp, and N. S. Young
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
N. Engl. J. Med.,
April 7, 2005;
352(14):
1413 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Fibbe
Telomerase Mutations in Aplastic Anemia
N. Engl. J. Med.,
April 7, 2005;
352(14):
1481 - 1483.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zimmermann, S. Glaser, R. Ketteler, C. F. Waller, U. Klingmuller, and U. M. Martens
Effects of Telomerase Modulation in Human Hematopoietic Progenitor Cells
Stem Cells,
September 1, 2004;
22(5):
741 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A.G. Van Ziffle, G. M. Baerlocher, and P. M. Lansdorp
Telomere Length in Subpopulations of Human Hematopoietic Cells
Stem Cells,
November 1, 2003;
21(6):
654 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yamaguchi, G. M. Baerlocher, P. M. Lansdorp, S. J. Chanock, O. Nunez, E. Sloand, and N. S. Young
Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Blood,
August 1, 2003;
102(3):
916 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Karadimitris, D. J. Araten, L. Luzzatto, and R. Notaro
Severe telomere shortening in patients with paroxysmal nocturnal hemoglobinuria affects both GPI- and GPI+ hematopoiesis
Blood,
July 15, 2003;
102(2):
514 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bogliolo, O. Cabre, E. Callen, V. Castillo, A. Creus, R. Marcos, and J. Surralles
The Fanconi anaemia genome stability and tumour suppressor network
Mutagenesis,
November 1, 2002;
17(6):
529 - 538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Callen, E. Samper, M. J. Ramirez, A. Creus, R. Marcos, J. J. Ortega, T. Olive, I. Badell, M. A. Blasco, and J. Surralles
Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia
Hum. Mol. Genet.,
February 1, 2002;
11(4):
439 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|